Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The state would pay a fixed annual amount for an unlimited supply of HCV drugs for its Medicaid program.
The Trump administration had proposed changing which meds were covered, including HIV and cancer drugs.
The proposal rolls back nondiscrimination policies of the Affordable Care Act, notably for transgender people and women who had abortions.
Insurance companies can no longer implement harmful co-pay accumulator policies.
A look at the supply chain that results in very high costs for HIV and hepatitis C medications.
The subscription-based model is the first of its kind.
Nearly 21 million Americans could lose coverage. Meanwhile, the GOP won’t offer a health care replacement until after 2020.
In fact, antiviral drugs account for nearly 14 percent of total drug costs in the program.
The patient advocacy coalition I Am Essential sent a letter to the HHS spelling out why the plan is dangerous.
Louisiana health officials are adopting the country’s first subscription model for hep C cures.
The American territory also does not cover liver transplants for sick people.
That’s according to an analysis of four large health systems from around the United States.
A new report by the National Viral Hepatitis Roundtable tracks the progress.
A national survey gauges HIV care providers’ views about the Affordable Care Act.
The drugs are set to come out in January 2019 with a list price of $24,000 for the most common dose for each.
New recommendations in the Annals of Internal Medicine would increase access to treatment.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.